NCT07851753 Lumbopelvic Stability in Gestational Diabetes Mellitus
| NCT ID | NCT07851753 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Gestatiaonl Diabetes Mellitus |
| Study Type | OBSERVATIONAL |
| Enrollment | 170 participants |
| Start Date | 2026-05-01 |
| Primary Completion | 2026-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 170 participants in total. It began in 2026-05-01 with a primary completion date of 2026-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this comparative cross-sectional study is to learn about the effects of gestational diabetes on lumbopelvic stability in primigravida subjects. The main question it aims to answer is: Does gestational diabetes effect lumbopelvic stability during pregnancy?
Eligibility Criteria
Inclusion Criteria: * Pregnant women (2nd trimester) * Primi gravida * Diagnosed cases of gestational diabetes mellitus (for case group) * Healthy pregnant women (for control group) * Singleton pregnancy * Ability to perform functional tests (ASLR and Y Balance Test) * BMI within normal to overweight range (e.g., 18.5-29.9 kg/m²) * Stable medical condition Exclusion Criteria: * • High-risk pregnancy (e.g., preeclampsia, placenta previa) * Previous spinal or pelvic surgery * History of low back pain with neurological deficit * Diagnosed spinal disorders (disc herniation, spondylolisthesis, severe scoliosis) * Pelvic fractures * Neurological disorders (e.g., stroke, neuropathy)
Contact & Investigator
imran Professor, Faculty of Rehabilitation & Allied Health Sciences, PhD
✉ imran.amjad@riphah.edu.pk📞 03324390125
hina gul gul
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07851753 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 40 Years, studying Gestatiaonl Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07851753 currently recruiting?
Yes, NCT07851753 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07851753 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07851753 clinical trial?
NCT07851753 is sponsored by Riphah International University. The principal investigator is hina gul gul at Riphah International University. The trial plans to enroll 170 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.